These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 2484221

  • 1. [Immunomodulator therapy in chronic viral hepatitis].
    Stanciu L.
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1989; 41(6):491-502. PubMed ID: 2484221
    [No Abstract] [Full Text] [Related]

  • 2. [Interferon therapy in chronic active viral hepatitis].
    Lengyel G, Fehér J.
    Orv Hetil; 1995 Jan 01; 136(1):3-7. PubMed ID: 7531317
    [Abstract] [Full Text] [Related]

  • 3. [Alternative treatment to interferon therapy in chronic viral hepatitis].
    Salmerón Escobar FJ.
    Gastroenterol Hepatol; 1995 Oct 01; 18(8):430-6. PubMed ID: 7584785
    [No Abstract] [Full Text] [Related]

  • 4. [Hepatological news (2). The twilight of immunosuppression in hepatitis B--the dawn of new methods?].
    Juszczyk J.
    Pol Tyg Lek; 1982 Nov 08; 37(43):1295-300. PubMed ID: 6761672
    [No Abstract] [Full Text] [Related]

  • 5. Levamisole therapy in chronic type hepatitis.
    Fattovich G, Alberti A, Realdi G.
    Hepatology; 1988 Nov 08; 8(1):196-7. PubMed ID: 3338714
    [No Abstract] [Full Text] [Related]

  • 6. [Theory and practice of pharmacotherapy of chronic hepatitis B].
    Juszczyk J.
    Przegl Epidemiol; 1989 Nov 08; 43(2):183-91. PubMed ID: 2479056
    [No Abstract] [Full Text] [Related]

  • 7. [Antiviral treatment of chronic hepatitis].
    Müller R.
    Internist (Berl); 1984 Dec 08; 25(12):728-34. PubMed ID: 6083989
    [No Abstract] [Full Text] [Related]

  • 8. [Clinical characteristics of chronic hepatitis B in children and the principles of its staged treatment].
    Gol'zand IV, Murav'eva NN, Goriacheva LG, Bulovskaia LN, Gorvat NA.
    Pediatriia; 1987 Dec 08; (3):40-4. PubMed ID: 3601536
    [No Abstract] [Full Text] [Related]

  • 9. Interferons for viral hepatitis.
    Terrault N, Feinman SV.
    Transfus Med Rev; 1995 Jan 08; 9(1):29-52. PubMed ID: 7536498
    [No Abstract] [Full Text] [Related]

  • 10. [Immunosuppressive therapy of chronic active hepatitis: results of a long-term follow-up].
    Musca A, Cordova C, Barnaba V, Levrero M, Zaccari C, Trinchieri F, Gnecchi M.
    Clin Ter; 1983 Jun 15; 105(5):403-9. PubMed ID: 6872479
    [No Abstract] [Full Text] [Related]

  • 11. [Should chronic active viral hepatitis be treated with drugs or not?].
    Schalm SW.
    Internist (Berl); 1981 Dec 15; 22(12):717-20. PubMed ID: 7033161
    [No Abstract] [Full Text] [Related]

  • 12. [Chronic hepatitis B: to treat or not to treat?].
    Fernández JL, Morgante P, Viola LA.
    Acta Gastroenterol Latinoam; 1989 Dec 15; 19(1):53-6. PubMed ID: 2481375
    [No Abstract] [Full Text] [Related]

  • 13. [Markers of chronic hepatitis B in children after completion of therapy with isoprinosine].
    Kowalik-Mikołajewska B, Barszcz T, Ladyzyńska E, Wojnarowski M.
    Pol Tyg Lek; 1989 Dec 15; 48(11-13):263-4. PubMed ID: 7694263
    [Abstract] [Full Text] [Related]

  • 14. [Current aspects of the therapy of chronic hepatitis (a review of the literature)].
    Cherednichenko TV.
    Vopr Okhr Materin Det; 1979 Nov 15; 24(11):43-8. PubMed ID: 388858
    [No Abstract] [Full Text] [Related]

  • 15. [What is assured in therapy of chronic viral hepatitis?].
    Manns MP, Böker KH.
    Internist (Berl); 1993 Dec 15; 34(12):1096-106. PubMed ID: 8106205
    [No Abstract] [Full Text] [Related]

  • 16. [Indicators of cellular immunity in various types of treatment of children with chronic hepatitis B].
    Idrisova RS, Tsoĭ IG.
    Pediatriia; 1984 Aug 15; (8):16-8. PubMed ID: 6333670
    [No Abstract] [Full Text] [Related]

  • 17. Experiences with Catergen treatment in chronic active hepatitis.
    Pár A, Paál M, Kádas I, Nagy I, Kerekes E, Jávor T.
    Ther Hung; 1983 Aug 15; 31(3):105-14. PubMed ID: 6400472
    [No Abstract] [Full Text] [Related]

  • 18. [Levamisole in the complex treatment of hepatitis B].
    Sokol AS, Vozianova ZhI, Zagorodnaia IS, Kovaleva NM, Kovbasko MA.
    Vrach Delo; 1987 Dec 15; (12):94-7. PubMed ID: 3502214
    [No Abstract] [Full Text] [Related]

  • 19. [Immunomodulating drugs, thymalin and T-activin in the treatment of chronic liver diseases].
    Iakhontova OI, Dudanova OP, Khavinson VKh.
    Sov Med; 1990 Dec 15; (6):85-8. PubMed ID: 2396134
    [No Abstract] [Full Text] [Related]

  • 20. Thymostimulin in the treatment of hepatitis B surface antigen-positive chronic active hepatitis. Controlled clinical trial--two years follow-up.
    Romeo F, Palmisano L, Arcoria D.
    Arzneimittelforschung; 1987 Apr 15; 37(4):450-6. PubMed ID: 3300664
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.